中文 | English
Return
Total: 425 , 1/43
Show Home Prev Next End page: GO
Author:(Hai Bo YANG)

5.Public-private-partnership in healthcare delivery reform of public hospitals

Juyang ZHANG ; Qing YANG ; Hai YAN ; Jian WANG ; Kui ZHANG ; Yumin WANG ; Bo YANG

Chinese Journal of Hospital Administration 2015;(10):726-728

6.Evaluation of dose-related effects of 2', 3', 5'-tri-O-acetyl-N6-(3-hydroxylaniline)adenosine using NMR-based metabolomics.

Zhao-Xia MIAO ; Liu YANG ; Chun-Ying JIANG ; Ying-Hong WANG ; Hai-Bo ZHU

Acta Pharmaceutica Sinica 2014;49(5):679-685

7.Recent advances in the quantification of drug metabolizing enzymes and transporters by proteomic approach.

Bo YANG ; Jing WANG ; Yu-ting CONG ; Liang-hai HU ; Jing-kai GU

Acta Pharmaceutica Sinica 2015;50(6):668-674

8.Enlightenment of adverse reaction monitoring on safety evaluation of traditional Chinese medicines.

Hai-bo SONG ; Xiao-xi DU ; Jing-tian REN ; Le YANG ; Xiao-xin GUO ; Yu PANG

China Journal of Chinese Materia Medica 2015;40(8):1620-1623

9.Opportunity and challenge of post-marketing evaluation of traditional Chinese medicine.

Xiao-Xi DU ; Hai-Bo SONG ; Jing-Tian REN ; Le YANG ; Xiao-Xin GUO ; Yu PANG

China Journal of Chinese Materia Medica 2014;39(18):3427-3429

10.Advance in studies on toxicity of aristolochic acid and analysis on risk factors.

Hai-Bo SONG ; Jing-Tian REN ; Le YANG ; Xiao-Xin GUO ; Xiao-Xi DU

China Journal of Chinese Materia Medica 2014;39(12):2246-2250

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 425 , 1/43 Show Home Prev Next End page: GO